|
generic zoloft Es generic zoloft, but generic pharmaceutical-makers like Teva will likely come out ahead. By Aaron Smith generic zoloft, CNNMoney.com staff writer April 4 generic zoloft, 2006: 5:13 PM EDT NEW YORK (CNNMoney.com) - Zoloft generic zoloft, the antidepressant with the household name generic zoloft, is going off patent this summer generic zoloft, forcing Pfizer to bid adieu to billions of dollars in annual sales. Where will the money go? Zoloft sales totaled $3.3 billion in 2005 generic zoloft, its last full year on the market generic zoloft, but the drug's patent expires on June 23. The patent loss means that generic manufacturers can begin making generic versions of the drug generic zoloft, which in turn drives down the price of the name-brand version. In the year following a drug patent los generic zoloft.
generic zoloft S generic zoloft, sales of the name-brand version typically plunge by 80 percent. This means that annual Zoloft sales will dip to $470 million for Pfizer (down $0.02 to $25.10 generic zoloft, Research) generic zoloft, according to Miller Tabak analyst Les Funtleyder. Sales of nearly half a billion might be plenty for smaller companies generic zoloft, but they don't mean much to Pfizer generic zoloft, which is the biggest drug maker in the world with $51.3 billion in 2005 revenue. But although nearly $2 billion in revenue will vanish from Pfizer's balance sheet once Zoloft goes off patent generic zoloft, this won't necessarily translate into more sales for its brand-name competitors generic zoloft, analysts say. " The branded antidepressents are not interchangeable generic zoloft, " said Barbara Ryan generic zoloft, analyst for Deutsche Bank North America. " This is unlikely to have much of an effect on the category." Zoloft has many competitors generic zoloft, including Effexor XR generic zoloft, a $3.5 billion drug from Wyeth (up $0.36 to $49.09 generic zoloft, Research) generic zoloft, Lexapro generic zoloft, a $1.9 billion drug from Forest Laboratories (unchanged at $44.40 generic zoloft, Research) generic zoloft, Paxil and Wellbutrin XL generic zoloft, each of them $1.1 billion drugs from GlaxoSmithKline (down $0.24 to $52.60 generic zoloft, Research) generic zoloft, and Cymbalta generic zoloft, a $680 million drug from Eli Lilly & Co (down $0.08 to $55.16 generic zoloft, Research). Analysts tend to be particularly bullish on Cymbalta generic zoloft, a recently-launched and fast-growing drug. But Zoloft patent's loss will translate .
generic zoloft Le generic zoloft, " said Barbara Ryan generic zoloft, analyst for Deutsche Bank North America. " This is unlikely to have much of an effect on the category." Zoloft has many competitors generic zoloft, including Effexor XR generic zoloft, a $3.5 billion drug from Wyeth (up $0.36 to $49.09 generic zoloft, Research) generic zoloft, Lexapro generic zoloft, a $1.9 billion drug from Forest Laboratories (unchanged at $44.40 generic zoloft, Research) generic zoloft, Paxil and Wellbutrin XL generic zoloft, each of them $1.1 billion drugs from GlaxoSmithKline (down $0.24 to $52.60 generic zoloft, Research) generic zoloft, and Cymbalta generic zoloft, a $680 million drug from Eli Lilly & Co (down $0.08 to $55.16 generic zoloft, Research). Analysts tend to be particularly bullish on Cymbalta generic zoloft, a recently-launched and fast-growing drug. But Zoloft patent's loss will translate i.
generic zoloft 
generic zoloft | | | | | |
generic zoloft
|
